MedTrace Logo

French Travelers' Knowledge of Risk of Acquiring ESBL-PE

NCT03339947 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 191

Last updated 2017-11-13

No results posted yet for this study

Summary

Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, the investigators aimed to determine, among French travelers attending a consultation for travel medicine, patients level of knowledge about the risk of acquiring MRE.

Conditions

  • Travel Medicine

Interventions

OTHER

Questionnaire

Sponsors & Collaborators

  • CHU de Reims

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2016-05-01
Completion
2016-06-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03339947 on ClinicalTrials.gov